A RISING STAR

IntelliPharmaCeutics is a pharmaceutical company specializing in controlled release drug delivery. Formed in mid-1998, it has already expanded its premises twice. In that time, it has amassed a formidable array of core assets, including seven proprietary drug delivery technologies, issued and pending patents, and a growing pipeline of ANDA's and NDA's. Significantly, its Chief Scientific Officers were responsible for the development of three FDA approved and commercially successful controlled release drug products covering six dosage strengths. These assets and achievements are combined with a great breadth of experience and know-how in its scientific staff and management across the complete spectrum of drug development, from design and formulation to regulatory approval.

IntelliPharmaCeutics fully deploys these assets to meet the drug delivery needs of its clients and partners. Its collaborative development and licensing arrangements with major established pharmaceutical companies are based on total confidentiality and well-earned trust. From there, the entire focus of the relationship is directed to getting the best drug product to market in the shortest possible time, on the premise that what is best for its clients will be best for itself.

It is a simple premise. If IntelliPharmaCeutics helps its partners to be rising stars, it will be one too.